To our knowledge, no previous publication has studied the cut-off level of serum sclerostin and CIMT to detect and diagnose DN, hence we recommend further studies on a wider scale to study the sensitivity of these markers as early detectors of DN. The gene discussed is SOST; the disease is liver dysplastic nodule.